Navigation Links
NCPA Applauds Pharmacy TRICARE Provisions in the Congressional Passage of the Defense Authorization Bill
Date:12/17/2007

ALEXANDRIA, Va., Dec. 17 /PRNewswire-USNewswire/ --- The National Community Pharmacists Association (NCPA) thanks Congress for including key pharmacy provisions in the Defense Authorization Act Conference Report for fiscal year 2008 it passed last week. These provisions allow community pharmacies in our military health care system (TRICARE) to continue dispensing prescription drug services in a patient-friendly and cost-efficient manner.

The current freeze on increases to retail pharmacy co-payments was extended, preventing patients from being penalized for having their prescriptions filled at retail pharmacies as opposed to mail-order pharmacies. The Department of Defense will be able to negotiate with drug manufacturers for prescription drug federal pricing discounts at retail pharmacies, as is currently the case with mail order pharmacies. In fact, the Congressional Budget Office estimates that the Defense Department will save $1.8 billion over the next five years by having these all-inclusive negotiation rights. In response Bruce Roberts, RPh, NCPA executive vice president and CEO, issued the following statement:

"Our military's sacrifice and service clearly warrants that they have the best health care possible, especially when our nation is at war. Part of that commitment must include prescription drug services, and through the years community pharmacies have been at the forefront of fulfilling those needs for our active duty military, veterans, and their families. Included in the Defense Authorization bill that just passed Congress were critical provisions allowing community pharmacies to continue that relationship. These provisions extend the rebates of the federal supply schedule pricing to include retail pharmacies, and there is a one-year freeze on the increases in co-pays for retail pharmacies. What is also noteworthy is that any incentives or mandates for mail order were not included.

"Congress chose the prudent course of action by working to level the playing field for community pharmacies, so they can remain a viable, cost-effective option for TRICARE patients who deserve a choice when deciding where to get their prescription drugs filled. Special thanks goes out to the Congressional leadership that made this possible: the chairs and ranking members of the Senate and House Armed Service Committees, Senators Carl Levin (D-Mich) and John McCain (R-Ariz.), and Representatives Ike Skelton (D-Mo.) and Duncan Hunter (R-Calif.)."

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
2. Fairness Coalition Applauds Senate Passage of Mental Health Parity Bill
3. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
4. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
5. Coalition to Protect Floridas Drivers Applauds Governor Crist for Adding PIP to Special Session
6. AGD Applauds Congressional Support of SCHIP Reauthorization
7. Tobacco-Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking
8. Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation
9. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
10. California Alliance Applauds Governors Support of Group Home Reform for Foster Youth
11. ASGE Applauds News of Drop in Colorectal Cancer Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... (PRWEB) , ... July 28, 2017 , ... Kevin Harrington, one of the original Sharks ... announce the launch of a new DRTV campaign with My Real Earth. , Most people ... our bodies is just as important as what we put in our bodies. After all, ...
(Date:7/28/2017)... ... July 28, 2017 , ... For over 20 years Sealy Baby has been ... babies. We take tremendous pride in using some of nature’s best materials while integrating ... and innovative crib mattresses and crib bedding for infants and ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... through an alliance of independent physicians, has launched a new educational series of ... Jersey’s new regulations governing the prescribing of pain medication. The first two episodes ...
(Date:7/27/2017)... ... July 27, 2017 , ... Patients with ... in a single office visit from Dr. Alejandro Kovacs. Dr. Kovacs is a ... East Texas patients, including Teeth-in-a-Day® dental implants in Longview, TX. ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... Verification to State Medicaid programs, Managed Care Organizations and Home Care Agencies, has ... The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies and multiple ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)...  The global market for liquid biopsy diagnostic and ... in 2016.  Although in early stages, the global market ... as a result of the gradual shift towards personalized ... of a significant number of new liquid biopsy tests ... biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology: